| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.6B | $4.2B | $1.0B | $3.7B | $0.8B | $0.7B | $0.7B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | $0.9B | $0.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.3B | $1.2B | $1.2B | $1.3B | $0.9B | $0.9B | $0.8B | $0.7B |
| Operating Income | $0.9B | $0.7B | $0.1B | $0.6B | $0.1B | $0.1B | $0.2B | $0.1B |
| Net Income | $0.5B | $0.3B | $0.0B | $0.3B | $1.0B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $2.34 | $1.46 | $0.03 | $1.40 | $5.31 | $0.53 | $0.44 | $0.55 |
| EPS (Diluted) | $2.32 | $1.45 | $0.03 | $1.40 | $5.27 | $0.53 | $0.43 | $0.53 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.1B | $11.0B | $11.1B | $11.7B | $12.6B | $7.3B | $7.1B | $7.0B |
| Current Assets | $2.0B | $1.8B | $1.5B | $1.5B | $2.6B | $1.1B | $0.9B | $0.8B |
| Cash & Equivalents | $0.9B | $0.7B | $0.5B | $0.6B | $1.8B | $0.5B | $0.3B | $0.2B |
| Total Liabilities | $6.6B | $6.7B | $7.0B | $7.4B | $8.6B | $4.7B | $4.8B | $5.1B |
| Current Liabilities | $1.2B | $1.1B | $1.0B | $0.9B | $1.4B | $0.7B | $0.6B | $0.5B |
| Stockholders' Equity | $4.4B | $4.2B | $4.0B | $4.2B | $3.9B | $2.5B | $2.2B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.8B | $0.6B | $0.3B | $0.8B | $0.8B | $0.8B | $0.6B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.3B | $-0.7B | $-2.2B | $-0.3B | $-0.2B | $-2.0B |
| Capital Expenditures | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.5B | $-0.3B | $-0.4B | $-0.8B | $2.8B | $-0.3B | $-0.5B | $1.5B |